307 related articles for article (PubMed ID: 27561426)
21. Proteomics: the tool to bridge the gap between the facts and fables of telomerase.
Thakkar D; Shervington A
Crit Rev Oncog; 2008; 14(4):203-15. PubMed ID: 19645682
[TBL] [Abstract][Full Text] [Related]
22. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
23. The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.
Bottoni P; Isgrò MA; Scatena R
Expert Rev Proteomics; 2016; 13(1):115-33. PubMed ID: 26567562
[TBL] [Abstract][Full Text] [Related]
24. Mass spectrometry based proteomics and metabolomics in personalized oncology.
Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
[TBL] [Abstract][Full Text] [Related]
25. Proteomics in cancer screening and management in gynecologic cancer.
Hu W; Wu W; Kobayashi R; Kavanagh JJ
Curr Oncol Rep; 2004 Nov; 6(6):456-62. PubMed ID: 15485615
[TBL] [Abstract][Full Text] [Related]
26. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
27. The ongoing evolution of proteomics in malignancy.
Dhamoon AS; Kohn EC; Azad NS
Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682
[TBL] [Abstract][Full Text] [Related]
28. Molecular profiling in the age of cancer genomics.
Lin J; Li M
Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106
[TBL] [Abstract][Full Text] [Related]
29. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
30. Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities.
Padhye BD; Nawaz U; Hains PG; Reddel RR; Robinson PJ; Zhong Q; Poulos RC
Pediatr Blood Cancer; 2024 Jun; 71(6):e30980. PubMed ID: 38556739
[TBL] [Abstract][Full Text] [Related]
31. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.
Paul D; Kumar A; Gajbhiye A; Santra MK; Srikanth R
Biomed Res Int; 2013; 2013():783131. PubMed ID: 23586059
[TBL] [Abstract][Full Text] [Related]
33. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
Ali M; Khan SA; Wennerberg K; Aittokallio T
Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in mass spectrometry-based proteomics of gastric cancer.
Kang C; Lee Y; Lee JE
World J Gastroenterol; 2016 Oct; 22(37):8283-8293. PubMed ID: 27729735
[TBL] [Abstract][Full Text] [Related]
35. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
36. Proteomic biomarkers in lung cancer.
Pastor MD; Nogal A; Molina-Pinelo S; Carnero A; Paz-Ares L
Clin Transl Oncol; 2013 Sep; 15(9):671-82. PubMed ID: 23606351
[TBL] [Abstract][Full Text] [Related]
37. Proteomics in epigenetics: new perspectives for cancer research.
Bartke T; Borgel J; DiMaggio PA
Brief Funct Genomics; 2013 May; 12(3):205-18. PubMed ID: 23401080
[TBL] [Abstract][Full Text] [Related]
38. Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.
Murray HC; Dun MD; Verrills NM
Expert Opin Drug Discov; 2017 May; 12(5):431-447. PubMed ID: 28286965
[TBL] [Abstract][Full Text] [Related]
39. Clinical applications of mass spectrometry-based proteomics in cancer: Where are we?
Boys EL; Liu J; Robinson PJ; Reddel RR
Proteomics; 2023 Apr; 23(7-8):e2200238. PubMed ID: 35968695
[TBL] [Abstract][Full Text] [Related]
40. Cancer: a proteomic disease.
Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
